Kunthi Pathmaraj
Melbourne, VIC, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Multidisciplinary Perspectives of Clinical Trials in Theranostics.
Journal: World journal of nuclear medicine
Published: November 12, 2025
Theranostics Implementation: Opportunities and Challenges.
Journal: World journal of nuclear medicine
Published: November 12, 2025
Assessment of Lean body mass using whole-body low-dose Ct from Pet/Ct to identify cancer Cachexia.
Journal: Cancer imaging : the official publication of the International Cancer Imaging Society
Published: November 11, 2025
Multidisciplinary Approach to Theranostics Around the World: Integration of Care Teams.
Journal: Journal of nuclear medicine technology
Published: September 04, 2025
Single- Versus Dual-Time-Point Imaging for Transthyretin Cardiac Amyloid Using 99mTc-Pyrophosphate.
Journal: Journal of nuclear medicine technology
Published: January 05, 2025
The importance of quality management systems in nuclear medicine departments.
Journal: Journal of medical radiation sciences
Published: February 19, 2024
A patient journey audit tool (PJAT) to assess quality indicators in a nuclear medicine service.
Journal: European journal of nuclear medicine and molecular imaging
Published: September 27, 2023
Evaluation of 18F-FMISO PET and 18F-FDG PET Scans in Assessing the Therapeutic Response of Patients With Metastatic Colorectal Cancer Treated With Anti-Angiogenic Therapy.
Journal: Frontiers in oncology
Published: September 14, 2020
Response Evaluation and Survival Prediction After PD-1 Immunotherapy in Patients with Non-Small Cell Lung Cancer: Comparison of Assessment Methods.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: July 29, 2020
Prevalence of hypoxia and correlation with glycolytic metabolism and angiogenic biomarkers in metastatic colorectal carcinoma.
Journal: European journal of nuclear medicine and molecular imaging
Published: June 14, 2020
First clinical study of a pegylated diabody 124I-labeled PEG-AVP0458 in patients with tumor-associated glycoprotein 72 positive cancers.
Journal: Theranostics
Published: June 12, 2020
Last Updated: 09/26/2026